Patent details

EP2041282 Title: SDF-I BINDING NUCLEIC ACIDS

Basic Information

Publication number:
EP2041282
PCT Application Number:
EP2007006387
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP077861607
PCT Publication Number:
WO2008009437
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SDF-I BINDING NUCLEIC ACIDS
French Title of Invention:
ACIDES NUCLÉIQUES DE LIAISON À SDF-I
German Title of Invention:
SDF-I BINDENDE NUKLEINSÄUREN
SPC Number:

Dates

Filing date:
18/07/2007
Grant date:
03/01/2018
EP Publication Date:
01/04/2009
PCT Publication Date:
24/01/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/01/2018
EP B1 Publication Date:
03/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/07/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/08/2022
 
 

Name:
TME PHARMA AG
Address:
Max-Dohrn-Strasse 8-10, 10589, Berlin, Germany (DE)

History of Owners

From:
27/12/2017
To:
05/08/2022

Name:
Noxxon Pharma AG
Address:
Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany (DE)

Agent

Name:
Office FREYLINGER S.A.
From:
14/02/2018
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
JAROSCH, Florian
Address:
Germany (DE)

2

Name:
MAASCH, Christian
Address:
Germany (DE)

3

Name:
EULBERG, Dirk
Address:
Germany (DE)

4

Name:
PURSCHKE, Werner
Address:
Germany (DE)

5

Name:
BUCHNER, Klaus
Address:
Germany (DE)

6

Name:
DINSE, Nicole
Address:
Germany (DE)

Priority

Priority Number:
06014957
Priority Date:
18/07/2006
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 38/00; C12N 15/11; C12Q 1/68;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/10
Publication date:
05/09/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201801
Publication date:
03/01/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20220000284A
Date Registered:
05/08/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
change of owners name
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TME PHARMA AG
Address:
Max-Dohrn-Strasse 8-10, 10589, Berlin, Germany (DE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
20
Annual Fee Amount:
300 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/07/2025
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
14/02/2018 Power Of Attorney 1
22/02/2018 Outgoing Correspondence 1
05/08/2022 Request For Change 1
08/08/2022 Outgoing Correspondence 1